24/7 Wall St. has picked out the biggest movers and winners on Wednesday, particularly biopharma companies making serious runs in the session.
A few biotech companies made fantastic runs in Thursday’s session. We have included information about each company, as well as recent trading activity and the consensus price target.
Cellectar Biosciences watched its shares skyrocket on Wednesday morning following the announcement that it has obtained a patent that covers CLR 1603, a phospholipid ether-paclitaxel.
Although the markets have made their comeback, some stocks are still slowing that recovery and punishing their shareholders. These companies hurt their shareholders last week.
April 15, 2016: Here are four stocks trading with relatively heavy volume among 8 equities making new 52-week lows in Friday’s session. The day’s NYSE and Nasdaq decliners led advancers...